article thumbnail

The Battle Over the Future of D&D

Plagiarism Today

Since the year 2000, much of what makes up the core of Dungeons & Dragons has been easily licensed for others to use. That’s because the Wizards of the Coast (WotC), the rightsholders, licensed the System Resource Document under the Open Gaming License (OGL). Though WotC has dabbled with other open licenses, OGL 1.0

Licensing 262
article thumbnail

CCC at the Charleston Conference 2023

Velocity of Content

On 27 November, The State of Scholarly Metadata: 2023 will be featured as a Virtual Poster Session. During the session, the panelists will discuss the current state of agreement reporting and review the specific industry reporting templates and guidelines they currently follow.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Cyntec Company, Ltd. v. Chilisin Electronics Corp., Chilisin America Ltd. Nos. 2022-1873, (Fed. Cir. October 16, 2023)

Intellectual Property Law Blog

Similarly, in the second case, Niazi Licensing Corporation v. Like the flawed calculations in Power Integrations and Niazi Licensing , the expert’s testimony here relied on data that failed to differentiate between infringing products and non-infringing products. Jude Medical S.C., 4th 1339, 1343–44 (Fed.

Art 260
article thumbnail

Nokia and Amazon Reach Licensing Deal to End Litigation Over Streaming Patents

IP Watchdog

In 2023, Nokia filed patent infringement suits against Amazon in multiple jurisdictions, including the United States, Germany, India, the UK, and at the Unified Patent Court, and against and HP in the United States, accusing the companies of infringing on multiple Nokia video streaming patents.

article thumbnail

Novartis signs Voluntary License Agreement with the Medicine Patent Pool for Nilotinib

IPilogue

In a landmark development , Novartis has signed a Voluntary Licensing Agreement with the Medicine Patent Pool (MPP) for its nilotinib drug, used in treating Chronic Myeloid Leukemia (CML) in adults and children as young as a year old. In terms of revenue, nilotinib accounted for $2.1 billion for Novartis last year.

Licensing 119
article thumbnail

European Commission publishes proposal for an EU regulation on the Compulsory Licensing of Patents

JD Supra Law

On 27 April 2023, the European Commission (the Commission) published its Proposal for a Regulation of the European Parliament and of the Council on compulsory licensing for crisis management (the Proposed Compulsory Licensing Regulation). By: Allen & Overy LLP

article thumbnail

3 Count: Ford’s Tough

Plagiarism Today

The new deal covers the years of 2023 through 2027. According to the lawsuit, AirPro violated the terms of Ford’s license agreement for their diagnostic software by transferring long-term licenses between different scanning tools. The new rate will start at 15.1% and rise to 15.35% by the end of the term.

Contracts 246